Drugs acting on Renin-Angiotensin-Aldosterone System Flashcards
1
Q
Components of RAAS
A
- Angiotensiongen converted to Angiotensin I
- by Renin
- Angiotensin I converted to Angiotensin II
- by ACE
- Angiotensin II acts on AT1 and AT2 receptors
2
Q
AT1 Receptor Effects
A
- Rapid Response: increases afterload
- increase vasoconstriction
- Increased NE release, decrease NE reuptake, inc response
- Increase catecholamine release: CNS, adrenal medulla
- Slow response: increases volume (Preload)
- Increase Na+ reabsorption
- Increased aldosterone
- Increased renal hemodynamics
- constriction, catecholamine release, sympathetic tone
- Non-hemodynamic response:
- increased proto-oncogenes
- Increased growth factors
- increases synth of ECM proteins
3
Q
Aliskiren
A
- Renin inhibitor
- Treat HTN
- Adverse: same as ARBs plus GI effects
4
Q
Captopril and Enalapril
A
- ACE inhibitors
- Prevent formation of angiotensin II
- Prevent degradation of bradykinin
- Use: HTN, CHF, HCM, MI, Renal failure/fibrosis, and Diabetes
- HTN: useful in pts w/ LV hypertrophy and ischemic heart disease
- less effective in black patients
- Better than diuretic/beta blockers in HTN diabetics for preventing CV events
- CHF: relax smooth muscle and allow increased EF, SV, and CO
- Decreases congestion by decreasing afterload
- Venodilation decrease preload and helps congestion
- slow diabetic neuropathy
- Contraindicated in Renal artery stenosis and elevated K+
- Adverse: hypotension, nonproductive cough, taste change, renal hemodynamic dysfunction, hyperkalemina, angioedema
- Interactions
- NSAIDs: reduce antihypertensive effect, renal toxic
- Digoxin: reduced dig clearance and false low
- K+ sparing diuretics: hyperkalemia
- Thiazide or loop diuretics: enhance hypotensive effects
5
Q
Losartan
A
- ARB: AT1 receptor blocker
- Interferes w/ angiotensin II binding to reeptor
- HTN:use w/ high or normal renin
- mono if ACE intolerant, or in combo w/ others
- Less effective in black pts
- CHF: reduces CV mortality and hospital admissions
- CAD: reduce CV events
- MI: reduce morbidity and mortality
- Stroke
- Contraindications and side effects similar to ACE
6
Q
Spironolactone and Eplerenone
A
- K sparing diuretics and aldosterone receptor antagonist
- Blocks action of aldosterone
- Aldosterone: secretion affected by angiotensin II, K+, ACTH
- receptors in kidney, brain, heart, vessels
- Actions: Na+ retention, K+ secretion, blood volume expansion, Increased BP
- Antagonists block these action
- HTN: used alone or w/ others
- CHF: reduces morbidity, mortality, and hospitalizations
- Contraindicated: hyperkalemia, cirrhosis
- Adverse: hyperkalemia , gynacomastia, impotence, dysmenorrhea
- Interactions: digioxin (affects clearing)